+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Recurrent laryngeal papillomatosis: successful treatment with human papillomavirus vaccination

Recurrent laryngeal papillomatosis: successful treatment with human papillomavirus vaccination

Archives of Disease in Childhood 96(5): 476-477

The authors describe the case of a 5-year-old girl with recurrent laryngeal papillomatosis (RLP) due to human papillomavirus (HPV) type 11, who required frequent surgical treatment. Complete recovery occurred after HPV vaccination (Gardasil). Confirmed remission of RLP has continued during the 17 months of follow-up since vaccination. The authors conclude that HPV vaccination may represent a new therapeutic option in this situation.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 055420028

Download citation: RISBibTeXText

PMID: 21220258

DOI: 10.1136/adc.2010.198184

Related references

Recurrent laryngeal papillomatosis with oesophageal involvement in a 2 year old boy: successful treatment with the quadrivalent human papillomatosis vaccine. International Journal of Pediatric Otorhinolaryngology 79(2): 262-266, 2015

Reliable detection of human papillomavirus in recurrent laryngeal papillomatosis and associated carcinoma of archival tissue. Journal of Medical Virology 87(5): 860-870, 2015

Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis. Laryngoscope 2019, 2019

Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. Journal of General Virology 73: 423-428, 1992

The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination. Vaccine 26(35): 4513-4518, 2008

Juvenile-Onset Recurrent Respiratory Papillomatosis: The Benefits of Quadrivalent Human Papillomavirus Vaccination Continue to Accrue. Journal of Infectious Diseases 217(2): 177-178, 2017

Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men Second Report: Negative Conversion of HPV in Laryngeal Secretions. Journal of Voice 32(4): 488-491, 2017

Effectiveness of the human papillomavirus (types 6, 11, 16, and 18) vaccine in the treatment of children with recurrent respiratory papillomatosis. International Journal of Pediatric Otorhinolaryngology 83: 94-98, 2016

Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11. Head and Neck 37(11): 1625-1632, 2016

Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men: First Report: Changes in HPV Antibody Titer. Journal of Voice 31(1): 104-106, 2016

Stagewise treatment of anterior commissure laryngeal web and recurrent laryngeal papillomatosis under endoscope. American Journal of Otolaryngology 35(3): 427-430, 2014

Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatric and Developmental Pathology 4(1): 68-72, 2001

Human fibroblast interferon adjuvant to CO2 laser in the treatment of recurrent juvenile laryngeal papillomatosis: experience with 7 cases. Tumori 75(3): 259-262, 1989

Recurrent laryngeal papillomatosis developing into laryngeal carcinoma with human papilloma virus (HPV) type 18: a case report. Journal of Laryngology and Otology 110(1): 75-77, 1996

Human papillomavirus laryngeal tracheal papillomatosis. Journal of Pediatric Health Care 28(5): 451-455, 2015